Ligand validation:6ML9

ACT: ACETATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ML9_ACT_E_302	66%	45%	0.124	0.93	1.02	1.1	-	-	0	0	100%	1
6ML9_ACT_E_303	48%	5%	0.195	0.94	2.98	2.3	1	1	3	0	100%	1
6MLO_ACT_E_301	70%	39%	0.154	0.972	0.84	1.54	-	1	4	0	100%	1
6MLI_ACT_E_302	30%	47%	0.209	0.872	0.71	1.32	-	-	0	0	100%	1
6MLN_ACT_E_303	21%	46%	0.158	0.766	0.73	1.35	-	-	0	0	100%	1
5LDS_ACT_B_1012	100%	61%	0.015	0.999	0.83	0.68	-	-	0	0	100%	1
2GH1_ACT_B_302	100%	7%	0.032	0.996	1.81	2.93	1	2	1	0	100%	1
4RS3_ACT_A_434	100%	55%	0.036	0.991	0.69	1.05	-	-	0	0	100%	1
8Q64_ACT_A_703	100%	38%	0.034	0.989	1.18	1.25	-	-	0	0	100%	1
2VB1_ACT_A_201	100%	8%	0.036	0.99	3.47	1.22	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.